Market Research Reports Search Engine (MRRSE), has announced the addition of a new report, titled ‘Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023’, to its database. The report states that the global mice model market was valued at US$1 bn in 2014 and is predicted to reach US$1.7 bn by 2023. The global mice model market is expected to log a 6.40% CAGR till 2023 due to an increasing number of mice model applications in the discovery of drugs and treatments.
Mice have always been considered a preferred model for biological studies as the mouse is a mammal carrying significant genetic resources and sophisticated genetic tools. Since ancient times, researchers and scientists have been experimenting on mice to study new medicines and treatments. The global mice model market is expected to develop rapidly during the forecast period due to the increasing use of mice as the primary mammal or model for drug discovery procedures. The global mice model market is segmented on the basis of geography, services, model types, and applications. By geography, the global mice model market is classified into Asia Pacific, North America, the Middle East and Africa, Europe, and Rest of the World. In terms of revenue, in 2014, the North America region dominated the global mice model market with the highest share. The Asia Pacific mice model market is predicted to grow the fastest till 2023.
The global mice model market features both regional and global players offering drug discovery services. Some of the prominent players in the global mice model market are Crescendo Biologics Limited, Charles River Laboratories, Deltagen Inc., Harlan Laboratories Inc., genOway S.A., Lexicon Pharmaceuticals, The Jackson Laboratory, TransGenic Inc., Immuno Genes AG, and SAGE Labs. On the basis of model types, the global mice model market is divided into inbred, outbred, spontaneous mouse, conditioned/surgically modified, hybrid/congenic, transgenic, transplantation, and knockout mouse. In 2014, the global mice model market was led by the inbred mice model sector with 29.60% share of the market.
Mice models are commonly used to study diseases such as Parkinson’s, Huntington’s, Becker, and Duchenne muscle dystrophy. In the past 25 years, 80% of the biomedical research and drug discoveries have been linked to mice model research. In recent years, treatments for various types of cancers have been discovered by using mice models.
Inquiry on this report @ www.mrrse.com/enquiry/353
The mice model service sector is predicted to expand at a 7.30% CAGR through the period between 2015 and 2023. Some of the applications of mice model in the drug discovery process are the development of therapeutic strategies for treating human diseases, target validation and identification, lead screening, and toxicity screening. Factors such as a rigid regulatory framework, increasing concerns regarding animal cruelty, and moral concerns are expected to negatively affect the growth of the global mice model market.
By application, the global mice model market is classified into immunology, oncology, diabetes, central nervous system, cardiovascular, and metabolism and regulation. Some of the services offered by the global mice model market to end-users include genetic testing, cryopreservation, quarantine services, model in-licensing, and pharmacology services.